Musaffa's Global Halal Trading Platform is Here!
Start Investing NowMDGL Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: November 07, 2025
Report Source: 2025 3rd Quarter Report
Madrigal Pharmaceuticals Inc. Stock Analysis MDGL
United States Health Care Large Cap Report: Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. The company is headquartered in West Conshohocken, Pennsylvania and currently employs 528 full-time employees. The company went IPO on 2007-02-06. The Company’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-b agonist designed to target key underlying causes of MASH. Rezdiffra is the medication approved by the United States Food and Drug Administration (FDA) for the treatment of MASH with moderate to advanced fibrosis (consistent with stages F2 to F3). Rezdiffra is a prescribed medicine used along with diet and exercise to treat adults with nonalcoholic steatohepatitis (NASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver. An ongoing Phase III outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (consistent with stage F4c).
Read More Madrigal Pharmaceuticals Inc (MDGL) Chart
Madrigal Pharmaceuticals Inc (MDGL) vs CBOE Volatility Index (VIX) Comparative Returns
Analysis of Madrigal Pharmaceuticals Inc (MDGL) stock performance compared to the broader market (CBOE Volatility Index (VIX)) across multiple timeframes.
YTD Performance
- Madrigal Pharma... (MDG...) -18.64%
- CBOE Volatility Index (VIX) 7.42%
Madrigal Pharma... Underperformed CBOE Volatility Index (VIX) by 26.06%
1Y Performance
- Madrigal Pharma... (MDG...) 39.28%
- CBOE Volatility Index (VIX) -3.02%
Madrigal Pharma... Outperformed CBOE Volatility Index (VIX) by 42.30%
3Y Performance
- Madrigal Pharma... (MDG...) 85.54%
- CBOE Volatility Index (VIX) -19.46%
Madrigal Pharma... Outperformed CBOE Volatility Index (VIX) by 105.00%
5Y Performance
- Madrigal Pharma... (MDG...) 287.62%
- CBOE Volatility Index (VIX) -51.47%
Madrigal Pharma... Outperformed CBOE Volatility Index (VIX) by 339.09%
Key Statistics of Madrigal Pharmaceuticals Inc (MDGL)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$483.90Volume
256.43KP/E Ratio (TTM)
-52 Week Range
Market Cap
11.11BAvg. Volume
320.68KDividend Yield
-Financial Metrics & Statements of Madrigal Pharmaceuticals Inc (MDGL)
Super Investors Invested in Madrigal Pharmaceuticals Inc (MDGL)
Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
John Paulson
% Portfolio:
29.46 Recent Activity:-8.71%
Jefferies Group
% Portfolio:
0 Recent Activity:-100.00%
George Soros
% Portfolio:
0 Recent Activity:-100.00%
Community-Curated Collections with Madrigal Pharmaceuticals Inc (MDGL) ( With MDGL )
View AllCommunity-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.
FAQ's for Madrigal Pharmaceuticals Inc (MDGL)
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Related Halal Stocks to Madrigal Pharmaceuticals Inc (MDGL)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
